[Lisuride in the treatment of hyperfunctioning hypophyseal adenomas]

Real-space path integration is impaired in Alzheimer's disease and mild cognitive impairment.

Behavioural brain research·2016

[Serious sepsis treatment in intensive care departments in the Czech Republic - EPOSS Project pilot results].

Vnitrni lekarstvi·2013

Collagenolytic potential of rat liver myofibroblasts.

Physiological research·2012

Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial.

British journal of cancer·2011

[Disturbance of synthesis of cholesterol and its precursors in clinically serious conditions].

Vnitrni lekarstvi·2011

Biochemical and pharmacological effects of mitoxantrone and acetyl-L-carnitine in mice with a solid form of Ehrlich tumour.

Chemotherapy·2011

Ernst Wodak - a world-leading vestibulologist of Czech descent, completely forgotten in his native country.

Casopis lekaru ceskych·2026

Obligations of healthcare providers when using artificial intelligence systems under the AI Act.

Casopis lekaru ceskych·2026

Life stories as a tool for preserving autonomy and dignity in people with dementia.

Casopis lekaru ceskych·2026

The advance directives institute in the context of discussions on assisted dying.

Casopis lekaru ceskych·2026

New-onset sexual dysfunction in men: cardiometabolic associations and a practical outpatient approach.

Casopis lekaru ceskych·2026

New paradigm of therapeutic antibiotic monitoring.

Casopis lekaru ceskych·2026

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Cureus·2026

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Frontiers in endocrinology·2026

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Canadian journal of kidney health and disease·2026

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Frontiers in pharmacology·2026

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Frontiers in molecular neuroscience·2026

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Therapeutic advances in neurological disorders·2026

Related Experiment Videos

[Lisuride in the treatment of hyperfunctioning hypophyseal adenomas]

Related Concept Videos

Real-space path integration is impaired in Alzheimer's disease and mild cognitive impairment.

[Serious sepsis treatment in intensive care departments in the Czech Republic - EPOSS Project pilot results].

Collagenolytic potential of rat liver myofibroblasts.

Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial.

[Disturbance of synthesis of cholesterol and its precursors in clinically serious conditions].

Biochemical and pharmacological effects of mitoxantrone and acetyl-L-carnitine in mice with a solid form of Ehrlich tumour.

Ernst Wodak - a world-leading vestibulologist of Czech descent, completely forgotten in his native country.

Obligations of healthcare providers when using artificial intelligence systems under the AI Act.

Life stories as a tool for preserving autonomy and dignity in people with dementia.

The advance directives institute in the context of discussions on assisted dying.

New-onset sexual dysfunction in men: cardiometabolic associations and a practical outpatient approach.

New paradigm of therapeutic antibiotic monitoring.

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Related Experiment Videos

[Lisuride in the treatment of hyperfunctioning hypophyseal adenomas]

Related Concept Videos

Related Articles